|
Meningococcal Meningitis Disease
Meningococcal meningitis disease is a serious, potentially
fatal illness caused by bacteria. Symptoms may resemble the flu
but progress rapidly and can often cause death within two days.
For those that survive, long term effects can include brain damage,
seizures, hearing loss or limb amputations.
Meningitis is contagious and is spread through air
droplets and direct contact with infected persons. It can be spread
through coughing, sneezing, kissing or sharing items like drinking
glasses, lip balm, eating utensils or cigarettes.
Adolescents and young adults are at increased risk
of contracting this disease. The reason for the increased risk
may be due to lifestyle factors common among these age groups,
such as living in crowded situations (dormitories), going to bars,
smoking, and irregular sleep habits.
However, the majority of cases among adolescents
are preventable by vaccination. The vaccine is a covered benefit,
paid for by most major insurance companies and Medicaid. Additionally,
the vaccine is available to VFC children (i.e., Medicaid eligible,
uninsured, American Indian or Alaskan Native, or underinsured
children that receive immunizations at a Federally Qualified Health
Center or Rural Health Center) that meet the ACIP recommended
coverage groups listed below.
Meningococcal immunization is recommended for the
following age groups:
- Adolescents aged 11-12 year old,
- Adolescents at high school entry (15 years old), or
- College freshman, through 18 years of age, who live in dormitories,
or
- Children 11 > years of age who are at increased
risk for meningococcal disease.
In addition to being vaccinated, young adults can reduce their
risk for contracting the disease by not sharing eating utensils,
beverages, cigarettes, etc.
For medical advice about meningococcal immunization, consult
your physician, college health service or local public health
department. |
